Scinai Immunotherapeutics Ltd. (SCNI) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -1.45M | -1.53M | -1.04M | -1.08M | -2.04M | -1.76M | -1.46M | -1.23M | -2.22M | -2.88M | -3.06M | 0 | -2.04M | -3.67M | -1.1M | -1.65M | -1.92M | -2.43M | -1.16M | -4.95M |
| Operating CF Margin % | -297.75% | -396.9% | -269.34% | -522.33% | -1213.1% | -619.01% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -39.49% | 12.74% | 28.84% | 12.16% | 8.28% | 38.87% | 52.17% | - | -9.02% | 21.53% | -176.83% | 100% | -6.21% | -51.07% | 4.38% | 66.63% | 36.24% | 29% | 88.11% | -0.22% |
| Net Income | 3.57M | -2.58M | -1.56M | -2.23M | 10.49M | -2.32M | -2.16M | -2.33M | 3.11M | -3.76M | -3.52M | -528.81K | 1.05M | -2.98M | -2.48M | 1.19M | -2.8M | -3.68M | -2.45M | -4.39M |
| Depreciation & Amortization | 451.77K | 353K | 351K | 499K | 498K | 494.19K | 156K | 84.91K | 145K | 147K | 138K | 0 | 98.2K | 145K | 134K | -114.47K | 189.24K | 185.16K | 180.93K | 188.54K |
| Stock-Based Compensation | 0 | 270K | 0 | 204K | 145K | 142K | 191K | 453K | 234K | 200K | 252K | 1.6M | 0 | 385K | 485K | 648.2K | 783.78K | 789.76K | 435.73K | 417.54K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6.08M | 145K | 10K | -24K | -13.11M | 46.81K | 438K | -3.39M | -4.79M | -2.03M | 2.98M | -1.07M | -1.05M | -686K | 548K | -4.2M | -281.19K | 918.97K | 341.83K | -1.73M |
| Working Capital Changes | 604.36K | 275K | 155K | 475K | -53K | -119K | -89K | 3.95M | -914K | 2.56M | -2.92M | 0 | -148.13K | -526K | 203K | 820.92K | 186.41K | -641.62K | 334.05K | 565.63K |
| Change in Receivables | 30.91K | -22K | -57K | 152K | -2K | -158K | 149K | -208K | -90K | -23K | 30.71K | 0 | -20.93K | -8K | 123K | 140.02K | 368.84K | -671.98K | 216.22K | 537.01K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 198.46K | 114K | 169K | -54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 2.74M | -3K | -9K | -23 | -4K | -6K | -2K | -234K | -20K | -377K | -6K | 0 | -23.58K | 35K | -521K | -105.24K | -4.03K | -32.82K | 4.49K | 99.87K |
| Capital Expenditures | -2.99K | -3K | -9K | -23 | -4K | -6K | -2K | -234K | -20K | -377K | -6K | 0 | -23.58K | 35K | -521K | -96.56K | -1.24K | -32.51K | -6.58K | -30.18K |
| CapEx % of Revenue | 0.61% | 0.78% | 2.33% | 0.01% | 2.38% | 2.11% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 2.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 495 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.68K | -2.79K | -307 | 11.06K | 129.56K |
| Cash from Financing | 10.97K | 1.48M | 104K | 2M | 8K | 12K | 1.42M | 10.67K | 1.09M | -3.96K | 6.93K | 0 | 240.76K | 0 | 0 | 8.4M | -306.44K | -97.22K | 12.51M | -97.07K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -95.22K | -97.22K | -91.51K | -97.07K |
| Equity Issued (Net) | 10.97K | 1.48M | 104K | 2.01M | 6.36K | 1.98K | 1.44M | -947K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -947K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -12.23K | 1.64K | 10.02K | -15.76K | 957.67K | 1.09M | 0 | 6.93K | 0 | 0 | 0 | 0 | 8.4M | -211.22K | 0 | 12.6M | 0 |
| Net Change in Cash | 1.3M | -18K | -946K | 926K | -2.04M | -1.75M | -44K | -1.47M | -1.15M | -3.29M | 10.93M | 0 | -11.42M | -4.11M | -1.99M | 6.76M | -1.48M | -2.3M | 11.6M | -4.3M |
| Free Cash Flow | -1.46M | -1.54M | -1.05M | -1.08M | -2.04M | -1.76M | -1.47M | -1.46M | -2.24M | -3.25M | -3.06M | 0 | -2.07M | -3.63M | -1.63M | -1.75M | -1.92M | -2.46M | -1.16M | -4.98M |
| FCF Margin % | -298.37% | -397.67% | -271.67% | -522.33% | -1215.48% | -621.13% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -38.58% | 12.87% | 28.33% | 26.25% | 8.92% | 45.77% | 52.2% | - | -8.1% | 10.39% | -88.5% | 100% | -8.01% | -47.65% | -39.91% | 64.9% | 51.84% | 35.24% | 88.5% | 4.69% |
| FCF per Share | -1538.11 | -0.97 | -1.30 | -1.33 | -2.42 | -2.77 | -2.89 | -4.86 | -4.78 | -9.63 | -9.47 | - | -11.10 | -19.44 | -8.73 | -12.04 | -13.40 | -17.16 | -8.76 | -43.21 |
| FCF Conversion (FCF/Net Income) | -0.41x | 0.74x | 0.50x | 0.48x | -0.19x | 0.76x | 0.68x | 0.53x | -0.72x | 0.76x | 0.87x | - | -1.94x | 1.23x | 0.45x | -1.39x | 0.68x | 0.66x | 0.47x | 1.13x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 143K | 108K | 0 | 0 | 725K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.39K | 14K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |